Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids

Diseases and Conditions Researched

Pain

What is the purpose of this trial?

The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.



Participation Guidelines

Age: 6 Years - 16 Years
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Purdue Pharma LP
Dates: August 30, 2010
Last Updated: March 20, 2013
Study HIC#: 1107008863
Clinicaltrials.gov ID: NCT01192295